Physiological Pacing for AV Block to Prevent Pacemaker-induced Cardiomyopathy

Launched by HOSPITAL CLINIC OF BARCELONA · Jan 17, 2022

Keywords

ClinConnect Summary

This clinical trial is exploring a new way to help patients with a condition called atrioventricular block, which affects how the heart beats. Traditionally, pacemakers are implanted to help manage this condition, but they can sometimes lead to heart problems over time. This study is looking at a different approach called physiological pacing, which may help prevent those issues. The trial is currently recruiting participants who are 18 years or older and have a good heart function (with a specific measurement called ejection fraction greater than 50%).

To join the study, participants need to agree to take part by signing a consent form, and they should be able to attend follow-up visits at the study center. Unfortunately, those with serious health problems that significantly lower their life expectancy or those with severe cognitive issues won't be eligible. If you or a loved one is considering joining this trial, you can expect to be part of a research effort aimed at improving heart treatments and potentially avoiding complications associated with traditional pacing methods.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • The patient must be ≥ 18 years of age.
• • The patient must indicate their acceptance to participate in the study by signing an informed consent document.
• • Patients with EF\> 50% and indication for pacemaker implantation due to atrial-ventricular block according to current clinical guidelines.
• Exclusion Criteria:
• • Inability to understand and sign the informed consent.
• • Patients with severe comorbidities and life expectancy \<1 year.
• • Patients with severe cognitive impairment or other comorbidities resulting in dependence for basic activities of daily life.
• • Patients who cannot come to our center to carry out the follow-up of the study.